Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

202170 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 10, Issue 3, pp. 237-246

Field-Weighted Citation Impact: 4.10